Last updated: April 24, 2026
What suppliers produce or supply alfuzosin hydrochloride (API)?
ALFUZOSIN HYDROCHLORIDE is supplied globally as a finished API by multiple manufacturers and as a sourcing product via specialty chemical distributors. Publicly visible sources typically fall into two buckets: (1) API manufacturers listing alfuzosin hydrochloride as an active product, and (2) distributors that resell the API from branded or contract-manufacturing supply chains.
API and distributor supply channels (examples visible in global trade catalogs and chemical marketplaces):
| Supplier (type) |
What they supply |
Typical use in pharma supply chains |
Source format |
| AK Scientific / AK Pharma (distributor/brand) |
Alfuzosin hydrochloride (CAS-listed) |
Reagent/sourcing for R&D, some commercial resales depending on distributor terms |
Chemical catalog listing |
| MedChemExpress (distributor/brand) |
Alfuzosin hydrochloride |
R&D sourcing |
Chemical catalog listing |
| TCI Chemicals (distributor/brand) |
Alfuzosin hydrochloride |
R&D sourcing |
Chemical catalog listing |
| BOC Sciences (distributor/brand) |
Alfuzosin hydrochloride |
R&D sourcing |
Chemical catalog listing |
| ChemScene (distributor/brand) |
Alfuzosin hydrochloride |
R&D sourcing |
Chemical catalog listing |
| Cayman Chemical (distributor/brand) |
Alfuzosin hydrochloride |
R&D sourcing |
Chemical catalog listing |
These distributors usually sell the chemical in research grades; commercial API procurement requires confirmation of DMF/CEP/CoA grade, regulatory documentation, and GMP status under the purchaser’s quality system.
Which pharmaceutical-grade API manufacturers are likely tied to commercial alfuzosin products?
For downstream branded alfuzosin products, the active ingredient is produced through regulated API manufacturing networks. Publicly visible manufacturer evidence is generally strongest through:
- Regulatory dossiers (DMF/ASMF holders)
- CEP/letter-of-access holders
- Commercial API listings on GMP-focused supplier directories
Because supplier identity depends on jurisdictional dossier holders and batch documentation, only “hard” supplier lists that are explicitly tied to GMP API supply for alfuzosin hydrochloride can be treated as procurement-grade. Public distributor listings alone do not establish GMP API status.
What dosing-product context matters for supplier selection?
Alfuzosin hydrochloride is the active ingredient in multiple controlled-release and immediate-release products across markets. Supplier choice typically hinges on whether the purchaser needs:
- GMP API suitable for branded tablets (commercial manufacturing)
- R&D/medchem grade for process development and screening
Procurement-grade vs R&D-grade split
| Procurement need |
Typical proof suppliers provide |
Common supplier category |
| GMP API |
DMF/ASMF, CEP (if applicable), GMP certificate, CoA per batch, impurity specs |
GMP API manufacturer or API distributor with regulatory-ready documentation |
| R&D material |
Catalog CoA, chemical identity specs, packaging for lab use |
Research chemical distributors |
What does “alfuzosin hydrochloride” specification procurement usually require?
To make supplier comparisons operational, procurement teams usually standardize incoming material around the following items:
Core identity and quality checkpoints
- Chemical identity: match to alfuzosin hydrochloride specification (typical CAS listing used by suppliers)
- Assay and impurities: defined impurity profile versus pharmacopeial or dossier targets
- Salt form: hydrochloride
- Water/solvent residuals: controlled to internal specs
- Polymorph/hydrate considerations (if relevant to downstream processing)
Packaging and documentation checkpoints
- GMP status (for API destined for medicinal products)
- CoA aligned with batch-specific results
- Supply chain traceability (COO, batch records referenced)
How to map supplier options into an actionable shortlist
Use a two-step filter: (1) regulatory-grade capability then (2) commercial reliability.
Step 1: Regulatory-grade capability screen
- Confirm the supplier can provide GMP API documentation for alfuzosin hydrochloride
- Verify whether they can support:
- DMF/ASMF (or letter-of-access)
- CEP where required
- QMS readiness for your market’s regulator expectations
Step 2: Commercial reliability screen
- Confirm:
- Lead time stability
- Batch-to-batch impurity consistency
- Quality deviations history (CAPA performance)
- Capacity for your annual projected demand
What suppliers can you contact immediately for sourcing?
Public chemical catalogs support immediate outreach for material supply. The practical approach is to treat these as leads, then qualify them to GMP/API documentation requirements.
Examples of readily searchable supplier brands/categories (catalog-visible):
- AK Scientific / AK Pharma
- MedChemExpress
- TCI Chemicals
- BOC Sciences
- ChemScene
- Cayman Chemical
These are effective starting points for R&D-grade acquisition and initial vendor onboarding, after which GMP API documentation must be validated for medicinal production use.
Key Takeaways
- ALFUZOSIN HYDROCHLORIDE sourcing divides into R&D chemical distributors and GMP API manufacturers; distributor listings typically do not, by themselves, establish pharmaceutical-grade API suitability.
- Immediate outreach targets include catalog-visible brands such as AK Scientific, MedChemExpress, TCI Chemicals, BOC Sciences, ChemScene, and Cayman Chemical, followed by strict qualification for GMP and dossier-ready documentation.
- Procurement-grade supplier selection should be driven by DMF/ASMF or CEP availability, batch CoA alignment to impurity specs, and stability of quality under commercial-scale manufacturing.
FAQs
Are alfuzosin hydrochloride suppliers the same as finished-drug manufacturers?
No. Finished-drug firms may source API from external manufacturers; supplier identity for alfuzosin API depends on dossier holders and commercial supply agreements.
Do chemical marketplaces guarantee GMP API quality?
No. Many marketplace-displayed products are sold for R&D and need qualification to confirm GMP API readiness for medicinal use.
What documentation should be required for commercial alfuzosin API procurement?
At minimum: batch-specific CoA, GMP evidence, and regulatory support such as DMF/ASMF access or CEP when required for your target market.
What spec areas typically drive supplier qualification for alfuzosin hydrochloride?
Assay, impurity profile, salt form confirmation, residual solvents/water, and consistency of those metrics across batches.
Is sourcing easier for R&D grade than for GMP API?
Yes. R&D grade is widely available via catalog suppliers, while GMP API requires regulatory-grade manufacturing proof and dossier readiness.
References
[1] AK Scientific. “Alfuzosin Hydrochloride” (product listing).
[2] MedChemExpress. “Alfuzosin Hydrochloride” (product listing).
[3] TCI Chemicals. “Alfuzosin Hydrochloride” (product listing).
[4] BOC Sciences. “Alfuzosin Hydrochloride” (product listing).
[5] ChemScene. “Alfuzosin Hydrochloride” (product listing).
[6] Cayman Chemical. “Alfuzosin Hydrochloride” (product listing).
